CSBR ▼ -0.4% - Champions Oncology, Inc. $CSBR - Champions Oncology Expands Integrated Radiopharmaceutical Development Platform with In-House SPECT/CT Imaging Champions Oncology shares declined 0.4% today following the company's announcement that it has expanded its integrated radiopharmaceutical development platform to include in-house SPECT/CT imaging capabilities. The addition of this imaging technology allows Champions to conduct more comprehensive diagnostics and development work internally, potentially streamlining its drug development pipeline for radiopharmaceutical candidates. 01-SEP-2026 09:01 AM ET